Inovio Pharmaceuticals Inc. Stock Rallies 5.2%, Outperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Inovio Pharmaceuticals Inc. rallied 5.2% to $1.21 on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 1.7% to 26,418.30 and the Dow Jones Industrial Average rising 0.6% to 51,778.04.

The stock's rise snapped a seven-day losing streak.

Inovio Pharmaceuticals Inc. closed 55.5% short of its 52-week high of $2.72, which the company reached on December 17th.

The stock outperformed some of its peers, as Johnson & Johnson rose 1.1% to $270.22, Statera Biopharma Inc. remained unchanged, and Pfizer Inc. rose 0.66% to $27.64.

Trading volume totaled 2.7 million, compared to the 50-day average of 4.1 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

September 17, 2026 16:35 ET (20:35 GMT)